NCT00306644View on ClinicalTrials.gov

Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

556

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Rosiglitazone

study drug

Trial Locations (1)

SE-205 02

GSK Investigational Site, Malmo

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY